Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer

Biomaterials

Volumn 26, Issue 10, 2005, Pages 1139-1144

  Christman, Karen L ^a   Fang, Qizhi ^b   Yee, Michael S ^c   Johnson, Kandice R ^d   Sievers, Richard E ^c   Lee, Randall J ^a,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Angiogenix Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Cardiac Electrophysiology   (United States)

Author keywords

Angiogenesis; Cardiac tissue engineering; Fibrin; Gene therapy

Indexed keywords

CARDIOLOGY; DISEASES; PROTEINS;

ISCHEMIC MYOCARDIUM; MYOCARDIAL INFARCTION; THERAPEUTIC ANGIOGENIC AGENTS;

BIOPOLYMERS;

BIOPOLYMER; FIBRIN; PLEIOTROPHIN; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTECHNOLOGY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; FEMALE; GENE ACTIVATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; INJECTION; INTERMETHOD COMPARISON; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT;

ANIMALS; CARRIER PROTEINS; CYTOKINES; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; FEMALE; FIBRIN TISSUE ADHESIVE; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 4644308743     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.04.025     Document Type: Article

References (37)

1. 2002 Heart and Stroke Statistical Update. In: American Heart Association.
2. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium. deleterious effects of unregulated expression Circulation. 102(8):2000;898-901
3. Schwarz E.R., Speakman M.T., Patterson M., Hale S.S., Isner J.M., Kedes L.H., Kloner R.A. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol. 35(5):2000;1323-1330
4. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., Symes J.F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 348(9024):1996;370-374
5. Rosengart T.K., Lee L.Y., Patel S.R., Kligfield P.D., Okin P.M., Hackett N.R., Isom O.W., Crystal R.G. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg. 230(4):1999;466-470. [discussion 470-2]
6. Rosengart T.K., Lee L.Y., Patel S.R., Sanborn T.A., Parikh M., Bergman G.W., Hachamovitch R., Szulc M., Kligfield P.D., Okin P.M., Hahn R.T., Devereux R.B., Post M.R., Hackett N.R., Foster T., Grasso T.M., Lesser M.L., Isom O.W., Crystal R.G. Angiogenesis gene therapy. phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease Circulation. 100(5):1999;468-474
7. Vale P.R., Isner J.M., Rosenfield K. Therapeutic angiogenesis in critical limb and myocardial ischemia. J Interv Cardiol. 14:2001;511-528
8. Symes J.F. Epicardial gene therapy and laser revascularization. Curr Cardiol Rep. 1:1999;335-343
9. Grines C.L., Watkins M.W., Helmer G., Penny W., Brinker J., Marmur J.D., West A., Rade J.J., Marrott P., Hammond H.K., Engler R.L. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 105(11):2002;1291-1297
10. Lazarous D.F., Unger E.F., Epstein S.E., Stine A., Arevalo J.L., Chew E.Y., Quyyumi A.A. Basic fibroblast growth factor in patients with intermittent claudication. results of a phase I trial J Am Coll Cardiol. 36(4):2000;1239-1244
11. Laham R.J., Chronos N.A., Pike M., Leimbach M.E., Udelson J.E., Pearlman J.D., Pettigrew R.I., Whitehouse M.J., Yoshizawa C., Simons M. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease. results of a phase I open-label dose escalation study J Am Coll Cardiol. 36(7):2000;2132-2139
12. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., Simons M. Therapeutic angiogenesis with basic fibroblast growth factor. technique and early results Ann Thorac Surg. 65:1998;1540-1544
13. Christman K., Fang Q., Sievers R.E., Kim A.J., Fok H.H., Candia A.F., Colley K.J., Lee R.J. Delivery of pleiotrophin plasmid induces neovasculature formation in ischemic myocardium. Mol Ther. 7(5):2003;S231
14. Bonadio J. Tissue engineering via local gene delivery. J Mol Med. 78(6):2000;303-311
15. Bonadio J., Smiley E., Patil P., Goldstein S. Localized, direct plasmid gene delivery in vivo. prolonged therapy results in reproducible tissue regeneration Nat Med. 5(7):1999;753-759
16. Fang J., Zhu Y.Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., McCauley L.K., Davidson B.L., Roessler B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA. 93(12):1996;5753-5758
17. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol. 17(6):1999;551-554
18. Labhasetwar V., Bonadio J., Goldstein S., Chen W., Levy R.J. A DNA controlled-release coating for gene transfer. transfection in skeletal and cardiac muscle J Pharm Sci. 87(11):1998;1347-1350
19. Christman K., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10:2004;403-409
20. Andree C., Voigt M., Wenger A., Erichsen T., Bittner K., Schaefer D., Walgenbach K.J., Borges J., Horch R.E., Eriksson E., Stark G.B. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng. 7(6):2001;757-766
21. Sievers R.E., Schmiedl U., Wolfe C.L., Moseley M.E., Parmley W.W., Brasch R.C., Lipton M.J. A model of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med. 10(2):1989;172-181
22. Wolfe C.L., Moseley M.E., Wikstrom M.G., Sievers R.E., Wendland M.F., Dupon J.W., Finkbeiner W.E., Lipton M.J., Parmley W.W., Brasch R.C. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation. 80(4):1989;969-982
23. Zhu B., Sun Y., Sievers R.E., Browne A.E., Pulukurthy S., Sudhir K., Lee R.J., Chou T.M., Chatterjee K., Parmley W.W. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol. 35(3):2000;787-795
24. Zhu B., Sun Y., Sievers R.E., Browne A.E., Lee R.J., Chatterjee K., Parmley W.W. Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. J Renin Angiotensin Aldosterone Syst. 2(2):2001;129-133
25. Springer M.L., Ip T.K., Blau H.M. Angiogenesis monitored by perfusion with a space-filling microbead suspension. Mol Ther. 1(1):2000;82-87
26. Kellar R.S., Landeen L.K., Shepherd B.R., Naughton G.K., Ratcliffe A., Williams S.K. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation. 104(17):2001;2063-2068
27. Li W., Tanaka K., Chiba Y., Kimura T., Morioka K., Uesaka T., Ihaya A., Sasaki M., Tsuda T., Yamada N. Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs. Am J Physiol Heart Circ Physiol. 284(1):2003;H23-30
28. Sahni A., Odrljin T., Francis C.W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 273(13):1998;7554-7559
29. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 96(12):2000;3772-3778
30. Boyce S.T., Holder I.A., Supp A.P., Warden G.D., Greenhalgh D.G. Delivery and activity of antimicrobial drugs released from human fibrin sealant. J Burn Care Rehabil. 15(3):1994;251-255
31. Deyerling W., Haverich A., Potel J., Hetzer R. A suspension of fibrin glue and antibiotic for local treatment of mycotic aneurysms in endocarditis - an experimental study. Thorac Cardiov Surg. 32(6):1984;369-372
32. Zilch H., Lambiris E. The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitis. Pharmacokinetic study and clinical results. Arch Orthop Trauma Surg. 106(1):1986;36-41
33. Kabuto M., Kubota T., Kobayashi H., Nakagawa T., Arai Y., Kitai R. Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas. Surg Neurol. 44(2):1995;151-156. [discussion 156-7]
34. Kipshidze N., Chekanov V., Chawla P., Shankar L.R., Gosset J.B., Kumar K., Hammen D., Gordon J., Keelan M.H. Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Tex Heart Inst J. 27(2):2000;196-200
35. Sierra D.H. Fibrin sealant adhesive systems. a review of their chemistry, material properties and clinical applications J Biomater Appl. 7(4):1993;309-352
36. Vailhe B., Ronot X., Tracqui P., Usson Y., Tranqui L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim. 33(10):1997;763-773
37. Bach T.L., Barsigian C., Chalupowicz D.G., Busler D., Yaen C.H., Grant D.S., Martinez J. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res. 238(2):1998;324-334